The impact of X-rays on the expressions of miR-130a/miR-25 and its potential role in the enhanced metastasis of A549 cell lines in vitro induced by X-rays
Source abstract
Abstract
We aimed to investigate the impact of X-rays on miR-130a and miR-25 expressions of A549 cell lines and to understand the mechanism of miR-130a and miR-25 on the regulation of invasion and metastasis of A549 cell lines. Human adenocarcinoma cells of the line A549 were cultured and radiated by X-rays at the absorbed doses of 2 and 4, respectively by linear accelerator. Transwell invasion and migration assay were employed to exam the metastasis ability of A549 cells post X-rays irradiation. Both the miRNA and mRNA were extracted from A549 cells at different time points post radiation. The expressions of miR-130a and miR-25, as well as the expressions of VEGF and CCR-7 mRNAs, were detected in A549 cells with 2 and 4 Gy X-rays radiation, respectively by real time PCR. Results were statistically analyzed by SAS 8.2 software, which showed that the invasiveness of A549 cells post 2 and 4 Gy X-rays increased significantly compared with that of untreated A549 cells (the migration cell numbers are 20, 48 and 62 in Group 0, 2 and 4 Gy X-rays, respectively). Furthermore, the expressions of miR-130a and miR-25 also increased significantly at the time-points of 1, 2, 4, and 8 h post radiation, and began to decrease to the control level at 12 h post radiation. VEGF and CCR-7 mRNAs were detected to be up-regulated 18 h post radiation and remained at a high level till 72 h post radiation. The expression of VEGF mRNA has a close correlation with that of CCR-7 mRNA, and the expression of miR-130a also has a correlation with that of VEGF and CCR-7mRNAs. It is concluded that the metastasis of A549 cells in vitro could be promoted by X-rays, and miR-130a might play a role in the metastasis of A549 cells via regulating the expressions of VEGF and CCR-7 mRNAs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: MicroRNA in disease regulation · Circular RNAs in diseases · Cancer-related molecular mechanisms research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Grosu H B, Eapen G A, Jimenez C A, et al. Lung cancer screening: Making the transition from research to clinical practice. Curr Opin Pulm Med, 2012, 18(4): 295–30310.1097/MCP.0b013e3283548139 ↗
2. Yu S L, Chen H Y, Chang G C, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 2008, 13(1): 48–5710.1016/j.ccr.2007.12.008 ↗
3. Hussain M U. Micro-RNAs (miRNAs): Genomic organisation, biogenesis and mode of action. Cell Tissue Res, 2012, 349(2): 405–41310.1007/s00441-012-1438-0 ↗
4. Manne U, Shanmugam C, Bovell L, et al. miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med, 2010, 4(5): 761–77010.2217/bmm.10.87 ↗
5. Wang H, Tan G, Dong L, et al. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One, 2012, 7(4): e3421010.1371/journal.pone.0034210 ↗
6. Lin P Y, Yu S L, Yang P C. MicroRNA in lung cancer. Br J Cancer, 2010, 103(8): 1144–114810.1038/sj.bjc.6605901 ↗
7. Wang X C, Tian L L, Wu H L, et al. Expression of miRNA-130a in Nonsmall Cell Lung Cancer. Am J Med Sci, 2010, 340(5): 385–38810.1097/MAJ.0b013e3181e892a0 ↗
8. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18(10): 997–100810.1038/cr.2008.282 ↗
9. Brieger J, Kattwinkel J, Berres M, et al. Impact of vascular endothelial growth factor release on radiation resistanse. Oncol Rep, 2007, 18(6): 1597–1601
10. Inoue Y, Ojima E, Watanabe H, et al. Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer? Oncol Rep, 2007, 18(2): 369–375
11. Jia J B, Wang W Q, Sun H C, et al. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest New Drugs, 2011, 29(5): 861–87210.1007/s10637-010-9435-1 ↗
12. Schmittgen T D, Livak K J. Analyzing real-time PCR data by the comparative CT method. Nat Protoc, 2008, 3(6): 1101–110810.1038/nprot.2008.73 ↗
13. Schmittgen T D, Lee E J, Jiang J. High-throughput real-time PCR. Methods Mol Biol, 2008, 429: 89–9810.1007/978-1-60327-040-3_7 ↗
14. Raffaele B, Matteo F, Stefano V, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol, 2009, 219(2): 214–22110.1002/path.2586 ↗
15. Farazi T A, Spitzer J I, Morozov P, et al. miRNAs in human cancer. J Pathol, 2011, 223(2): 102–11510.1002/path.2806 ↗
16. Cha H J, Shin S, Yoo H, et a1. Identification of ionizing radiation-Responsive microRNAs in the IM9 human B lymphoblastic cell line. Int J Oneol, 2009, 34(6): 1661–1668
17. Simone N L, Souh B P, Ly D, et al. Ionizing radiation-induced oxidative stings alters miRNA expression. PLoS One, 2009, 4(7): e637710.1371/journal.pone.0006377 ↗
18. Pourgholami M H, Morris D L. Inhibitors of vascular endothelial growth factor in cancer. Cardiovasc Hematol Agents Med Chem, 2008, 6(4): 343–34710.2174/187152508785909528 ↗
19. Murphy P M. Chemokines and the molecular basis of cancer metastasis. N Engl J Med, 2001, 345(11): 833–83510.1056/NEJM200109133451113 ↗
20. Li N, Fu H, Tie Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human gepatocellular carcinoma cells. Cancer Lett, 2009, 275(1): 44–5310.1016/j.canlet.2008.09.035 ↗
21. Sayed D, Rane S, Lypowy J, et al. MicroRNA-21 targets Sprouty 2 and promotes cellular outgrowths. Mol Biol Cell, 2008, 19(8): 3272–328210.1091/mbc.E08-02-0159 ↗
22. Valastyan S, Benaich N, Chang A, et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes, 2009, 23(22): 2592–259710.1101/gad.1832709 ↗
23. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 2009, 137(6): 1032–104610.1016/j.cell.2009.03.047 ↗
24. Chen Y, Gorski D H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood, 2008, 111(3): 1217–122610.1182/blood-2007-07-104133 ↗
25. Gibcus J H, Menkema L, Mastik M F, et al. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res, 2007, 13(21): 6257–626610.1158/1078-0432.CCR-07-1247 ↗
26. Zheng S L, Stevens V L, Wiklund F, et al. Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev, 2009, 18(6): 1815–182010.1158/1055-9965.EPI-08-0983 ↗
27. Wu W H, Hu C P, Chen X P, et al. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens, 2011, 24(10):1087–109310.1038/ajh.2011.116 ↗
28. Acunzo M, Visone R, Romano G, et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene, 2012, 31(5): 634–64210.1038/onc.2011.260 ↗